You are here
- Home
- Therapy Areas
- Oncology/Infection
A Phase I, Open-Label Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies
- Disease
- solid tumour
- Drug Name
- AZD6244
- Generic Name
- AZD6244
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Jul 7, 2008
- Study Name
- D1532C00020
- Study Id
- D1532C00020
- ClinicalTrials.gov ID
- NCT00710515
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
